Free Trial

Intuitive Surgical (ISRG) Competitors

Intuitive Surgical logo
$537.99 -5.42 (-1.00%)
Closing price 04:00 PM Eastern
Extended Trading
$539.55 +1.56 (+0.29%)
As of 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ISRG vs. ABT, BSX, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STE

Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Abbott Laboratories (ABT), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry.

Intuitive Surgical vs. Its Competitors

Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Intuitive Surgical has a beta of 1.67, meaning that its stock price is 67% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.

Intuitive Surgical currently has a consensus price target of $588.95, suggesting a potential upside of 9.47%. Abbott Laboratories has a consensus price target of $142.61, suggesting a potential upside of 4.70%. Given Intuitive Surgical's higher possible upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
1 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.70
Abbott Laboratories
0 Sell rating(s)
6 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.76

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Abbott Laboratories had 11 more articles in the media than Intuitive Surgical. MarketBeat recorded 65 mentions for Abbott Laboratories and 54 mentions for Intuitive Surgical. Intuitive Surgical's average media sentiment score of 1.51 beat Abbott Laboratories' score of 1.26 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
50 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Abbott Laboratories
54 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Abbott Laboratories has a net margin of 31.89% compared to Intuitive Surgical's net margin of 28.41%. Abbott Laboratories' return on equity of 19.01% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical28.41% 14.43% 12.81%
Abbott Laboratories 31.89%19.01%10.82%

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$8.35B23.09$2.32B$6.8278.88
Abbott Laboratories$41.95B5.65$13.40B$7.7117.67

Summary

Intuitive Surgical beats Abbott Laboratories on 9 of the 17 factors compared between the two stocks.

Get Intuitive Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ISRG vs. The Competition

MetricIntuitive SurgicalMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$192.83B$6.83B$5.52B$8.86B
Dividend YieldN/A1.03%5.36%4.13%
P/E Ratio78.8827.0926.3919.77
Price / Sales23.09116.15408.83110.45
Price / Cash66.8121.4025.8827.49
Price / Book11.594.707.915.36
Net Income$2.32B$171.62M$3.15B$248.34M
7 Day Performance2.85%0.02%1.04%1.28%
1 Month Performance-2.39%9.72%5.36%5.45%
1 Year Performance23.32%23.26%32.71%18.02%

Intuitive Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ISRG
Intuitive Surgical
4.6975 of 5 stars
$537.99
-1.0%
$588.95
+9.5%
+22.2%$192.83B$8.35B78.8815,638Positive News
ABT
Abbott Laboratories
4.8971 of 5 stars
$133.04
+0.0%
$142.61
+7.2%
+31.0%$231.28B$41.95B17.24114,000Positive News
BSX
Boston Scientific
4.6004 of 5 stars
$102.11
+0.8%
$116.09
+13.7%
+39.5%$150.99B$16.75B74.4953,000Trending News
SYK
Stryker
4.6362 of 5 stars
$378.43
+0.8%
$427.30
+12.9%
+16.3%$144.30B$22.60B51.0953,000Positive News
MDT
Medtronic
4.867 of 5 stars
$85.93
-0.5%
$97.87
+13.9%
+10.8%$110.08B$33.54B23.7195,000Positive News
Analyst Upgrade
BDX
Becton, Dickinson and Company
4.7396 of 5 stars
$169.58
+0.7%
$219.22
+29.3%
-26.3%$48.58B$20.18B32.3574,000
EW
Edwards Lifesciences
4.3365 of 5 stars
$74.99
+1.6%
$80.20
+7.0%
-15.2%$43.97B$5.44B10.7115,800News Coverage
Positive News
IDXX
IDEXX Laboratories
3.714 of 5 stars
$524.06
+0.0%
$546.00
+4.2%
+10.1%$42.11B$3.90B48.3911,000Positive News
Analyst Forecast
RMD
ResMed
4.5774 of 5 stars
$253.20
-0.2%
$259.33
+2.4%
+34.9%$37.09B$4.69B28.399,980Positive News
DXCM
DexCom
4.8867 of 5 stars
$79.64
-0.5%
$98.50
+23.7%
-23.0%$31.22B$4.03B59.4210,300Positive News
Analyst Downgrade
Insider Trade
Gap Down
STE
STERIS
4.7102 of 5 stars
$236.09
+0.2%
$263.83
+11.8%
+9.3%$23.24B$5.46B38.1017,787Positive News

Related Companies and Tools


This page (NASDAQ:ISRG) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners